Yanai Shlomo

CIK 00015626459 companiesBRIDGEWATER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001562645

Recent Transactions

50 trades

Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-05-07+34,819→ 320,804 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-05-07−34,819→ 0 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-05-06+19,824→ 19,824 total
Award
Philip Morris International Inc.$PM
Common Stock
2026-05-06$169.93/sh+1,119→ 10,120 total
Award
Philip Morris International Inc.$PM
Common Stock
2025-05-07$174.82/sh+1,002→ 8,759 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-05-06+34,819→ 34,819 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-05-05+40,258→ 285,985 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-05-05−40,258→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-05-10−76,453→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-05-10+76,453→ 245,727 total
Award
Philip Morris International Inc.$PM
Common Stock
2024-05-08$97.84/sh+1,789→ 7,501 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-05-02+40,258→ 40,258 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-05-10−80,128→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-05-10+80,128→ 169,274 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-05-09+76,453→ 76,453 total
Award
Philip Morris International Inc.$PM
Common Stock
2023-05-03$96.58/sh+1,812→ 5,506 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-05-09+80,128→ 80,128 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-05-08−35,406→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2022-05-08+35,406→ 89,146 total
Award
Philip Morris International Inc.$PM
Common Stock
2022-05-04$99.53/sh+1,759→ 3,598 total
Disposition to Issuer
W R GRACE & CO
Common Stock, par value $0.01 per share
2021-09-22−6,973→ 0 total
Award
W R GRACE & CO
Common Stock, par value $0.01 per share
2021-05-11+1,683→ 6,973 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2021-05-06−46,218→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2021-05-06+46,218→ 53,740 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2021-05-05+35,406→ 35,406 total
Award
Philip Morris International Inc.$PM
Common Stock
2021-05-05$95.17/sh+1,839→ 1,839 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-12-15+7,522→ 7,522 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2020-12-15−7,522→ 0 total
Award
W R GRACE & CO
Common Stock, par value $0.01 per share
2020-05-12+2,280→ 5,290 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2020-05-05+46,218→ 46,218 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option
2019-12-14+28,506→ 28,506 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2019-12-14+7,522→ 7,522 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+1,613→ 0 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+2,140→ 0 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+1,577→ 0 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$40.06/sh+2,766→ 35,796 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+3,863→ 0 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy
2019-12-04+2,766→ 0 total
Sale
CAMBREX CORP
Common Stock
2019-12-04$60.00/sh−35,796→ 0 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$58.98/sh+1,577→ 31,050 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+6,371→ 0 total
Exercise/Conversion
CAMBREX CORP
Stock Option (right to buy)
2019-12-04+1,980→ 0 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$12.90/sh+6,371→ 21,857 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$41.23/sh+2,140→ 27,860 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$45.12/sh+1,613→ 29,473 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$53.70/sh+1,980→ 33,030 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2019-12-04$21.70/sh+3,863→ 25,720 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2019-06-20$3.00/sh+126,050→ 126,050 total
Award
W R GRACE & CO
Common Stock, par value $0.01 per share
2019-05-08+1,532→ 3,010 total
Award
CAMBREX CORP
Common Stock
2019-04-24+2,247→ 15,486 total

Yanai Shlomo

Recent Transactions

Companies

Recent Filings

Address